Array BioPharma Slaps $192M Lawsuit on AstraZeneca Over Cancer Drug Royalties Post author:Sam Post published:February 1, 2018 Post category:BioPharma AstraZeneca did not immediately respond to a request for comment. Source: BioSpace You Might Also Like SAGE Therapeutics Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity February 16, 2017 Amicus Investors Cheer as the FDA Shaves Four Months Off Its Fabry Drug Review Date February 11, 2018 Illumina Accelerator in the Bay Area Makes Room for 5 New Biotech Startups July 27, 2017
SAGE Therapeutics Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity February 16, 2017
Amicus Investors Cheer as the FDA Shaves Four Months Off Its Fabry Drug Review Date February 11, 2018
